Blog
Maplebear (CART) Q2 Earnings and Revenues Beat Estimates
Maplebear (CART) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.2 per share a year ago. These figures
GigaCloud Technology Inc. (GCT) Q2 Earnings and Revenues Surpass Estimates
GigaCloud Technology Inc. (GCT) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.65 per share a year ago
GoDaddy (GDDY) Q2 Earnings and Revenues Top Estimates
GoDaddy (GDDY) came out with quarterly earnings of $1.41 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.1 per share a year ago. These figures are
Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Lags Revenue Estimates
Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to a loss of $0.51 per share a year ago
Akamai Technologies (AKAM) Surpasses Q2 Earnings and Revenue Estimates
Akamai Technologies (AKAM) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.58 per share a year ago
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
BioLife Solutions, Inc. (BLFS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.06 per share a year ago. These
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.08 per share a year ago. These figures
Expedia (EXPE) Beats Q2 Earnings and Revenue Estimates
Expedia (EXPE) came out with quarterly earnings of $4.24 per share, beating the Zacks Consensus Estimate of $4.14 per share. This compares to earnings of $3.51 per share a year ago. These figures
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.94 per share a year
Texas Roadhouse (TXRH) Lags Q2 Earnings Estimates
Texas Roadhouse (TXRH) came out with quarterly earnings of $1.86 per share, missing the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $1.79 per share a year ago. These
Clipper Realty Inc. (CLPR) Beats Q2 FFO Estimates
Clipper Realty Inc. (CLPR) came out with quarterly funds from operations (FFO) of $0.2 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to FFO of $0.17 per share a
Ascend Wellness Holdings, Inc. (AAWH) Reports Q2 Loss, Misses Revenue Estimates
Ascend Wellness Holdings, Inc. (AAWH) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.1 per share a year ago
The Trade Desk (TTD) Lags Q2 Earnings Estimates
The Trade Desk (TTD) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.39 per share a year ago. These
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue Estimates
Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.34 per share a year ago. These
Cytokinetics (CYTK) Reports Q2 Loss, Tops Revenue Estimates
Cytokinetics (CYTK) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus Estimate of a loss of $1.34. This compares to a loss of $1.31 per share a year ago. These figures are
Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates
Arcellx, Inc. (ACLX) came out with a quarterly loss of $0.94 per share versus the Zacks Consensus Estimate of a loss of $1.03. This compares to a loss of $0.51 per share a year ago. These figures
Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates
Dynavax Technologies (DVAX) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.08 per share a year ago
Top Research Reports for NVIDIA, Palantir & Coca-Cola
Thursday, August 7, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA
Buy the Spike in AppLovin Stock after Q2 earnings?
AppLovin APP continued its growing popularity as one of the market’s top momentum stocks after exceeding its Q2 expectations on Wednesday evening.
The marketing and technology provider for apps has
Appian (APPN) Reports Q2 Earnings: What Key Metrics Have to Say
Appian (APPN) reported $170.64 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 16.5%. EPS of $0 for the same period compares to -$0.26 a year ago.
The
Compared to Estimates, Targa Resources (TRGP) Q2 Earnings: A Look at Key Metrics
Targa Resources, Inc. (TRGP) reported $4.26 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 19.6%. EPS of $2.87 for the same period compares to $1.33 a
Sabre (SABR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, Sabre (SABR) reported revenue of $687.15 million, down 10.4% over the same period last year. EPS came in at -$0.02, compared to -$0.05 in the year-ago quarter.
The
Is CVS a Smart Buy Now on Strong Q2, Low Valuation & Long-Term Upside?
Investors responded with optimism following CVS Health’s CVS second-quarter 2025 earnings release last week, buoyed by better-than-expected earnings and revenue growth, improved segment performance
Epam (EPAM) Beats Q2 Earnings Estimates (Revised)
Epam (EPAM) came out with quarterly earnings of $2.77 per share, missing the Zacks Consensus Estimate of $2.61 per share. This compares to earnings of $2.45 per share a year ago. These figures are



